Stefano Rusconi to HIV Protease Inhibitors
This is a "connection" page, showing publications Stefano Rusconi has written about HIV Protease Inhibitors.
Connection Strength
0.278
-
Durability of dolutegravir plus boosted darunavir as salvage or simplification of salvage regimens in HIV-1 infected, highly treatment-experienced subjects. HIV Clin Trials. 2018 12; 19(6):242-248.
Score: 0.143
-
Potential associations between atazanavir exposure and clinical outcome: a pharmacokinetic sub-study from the MODAt randomized trial. New Microbiol. 2018 Apr; 41(2):106-111.
Score: 0.136